Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin Dosing Regimens in Critically Ill Patients
NCT00351663Phase 4Completed
- Sponsor
- Shaare Zedek Medical Center
- Start
- Feb 2007
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thrombosis, sponsored by Shaare Zedek Medical Center. Started Feb 2007; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thrombosis
Beyond the preview
Go deeper on NCT00351663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351663.